Supplementary Figure 1 . Constructs tested to optimize the LACE system. Top panel, the N-terminal fragment of CRY2 (CRY2PHR, as previously described 1 ) or full-length CRY2 (CRY2FL) is fused to the VP64 transactivation domain. CRY2FL-VP64 contains two SV40 NLS sequences and an N-terminal FLAG tag. Bottom panel, dCas9 was fused to the N-terminal fragment of CIB1 (CIBN) at it's N-, C-, or N-and C-terminus. Each construct contains a FLAG tag at the N-terminus of dCas9 and two SV40 NLS sequences.
CRY2FL-dCas9 and CIBN-VP64 constructs were assembled and tested together, but did not result in activation of gene expression for unknown reasons. 
Supplementary Figure 4.
HEK293T cells were co-transfected with the LACE system or dCas9-VP64, an eGFP reporter, and a gRNA that targeted 8 identical DNA sites upstream of eGFP and a minimal CMV promoter. Cells that received the LACE system were either illuminated or incubated in the dark for 24 hours. Cells were transfected with the eGFP reporter and an empty plasmid as a negative control. Green = GFP, blue = DAPI. Scale bar = 200 um. 
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